Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study

Steven V Edelman, Daisy S Ng-Mak, Mark A Fusco, David Ashton, Ted E Okerson, Q Liu, J Jin, John Dixon

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)


The 5-year, open-label, prospective, observational helping evaluate reduction in obesity (HERO) study (N = 1106) examines efficacy and safety of the LAP-BAND laparoscopic adjustable gastric band (LAGB) in obese patients. This interim analysis assessed the control of type 2 diabetes (T2D), 1 year after the implantation of the LAGB.
Original languageEnglish
Pages (from-to)1009 - 1015
Number of pages7
JournalDiabetes, Obesity and Metabolism
Issue number10
Publication statusPublished - 2014

Cite this